| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 33.065 | 37.967 | 82.376 | 48.103 | 83.492 | 85.598 |
| Total Income - EUR | - | - | - | - | 33.065 | 37.967 | 82.376 | 48.103 | 83.492 | 85.599 |
| Total Expenses - EUR | - | - | - | - | 8.041 | 8.111 | 9.101 | 14.935 | 22.162 | 26.548 |
| Gross Profit/Loss - EUR | - | - | - | - | 25.024 | 29.855 | 73.275 | 33.168 | 61.330 | 59.051 |
| Net Profit/Loss - EUR | - | - | - | - | 24.693 | 29.502 | 72.451 | 32.713 | 60.571 | 57.815 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anise Health Advice S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 7 | 0 | 0 | 14.146 | 11.127 | 8.205 |
| Current Assets | - | - | - | - | 25.077 | 29.921 | 73.857 | 24.356 | 55.486 | 56.855 |
| Inventories | - | - | - | - | 0 | 0 | 6 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 32.352 | 23.320 | 51.835 | 50.477 |
| Cash | - | - | - | - | 25.077 | 29.921 | 41.499 | 1.035 | 3.651 | 6.378 |
| Shareholders Funds | - | - | - | - | 24.735 | 29.544 | 72.492 | 32.762 | 60.619 | 57.863 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 349 | 377 | 1.365 | 5.740 | 5.994 | 7.196 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Anise Health Advice S.r.l.